These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 18792813)

  • 1. [Obtain best usage of meropenem dose in severe infections. Results of an observational multicenter study].
    Alvarez-Sánchez B; Alvarez-Lerma F; Romero J; Fernández L; Ruiz F; Sancho H
    Rev Esp Quimioter; 2008 Sep; 21(3):143-8. PubMed ID: 18792813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of antimicrobial therapy in severe nosocomial infections: empiric choices, proportion of appropriate therapy, and adaptation rates--a multicentre, observational survey in critically ill patients.
    Vogelaers D; De Bels D; Forêt F; Cran S; Gilbert E; Schoonheydt K; Blot S;
    Int J Antimicrob Agents; 2010 Apr; 35(4):375-81. PubMed ID: 20122817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Multicentre study of comparative efficacy of meropenem and combined regimens for empirical antibacterial therapy of severe nosocomial infections: results of clinical and pharmacoeconomic analysis].
    Iakovlev SV; Beloborodov VB; Sidorenko SV; Iakovlev VP; Grigor'ev KB; Eliseeva EV; Kon EM; Levit AL; Kostina GV; Kuprenkov AV; Mukhacheva SIu; Saturnov AV; Sergeev IN; Spasov GP; Stakanov AV; Ushakova MA
    Antibiot Khimioter; 2006; 51(7):15-27. PubMed ID: 18035730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.
    Lucasti C; Jasovich A; Umeh O; Jiang J; Kaniga K; Friedland I
    Clin Ther; 2008 May; 30(5):868-83. PubMed ID: 18555934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelled target attainment after meropenem infusion in patients with severe nosocomial pneumonia: the PROMESSE study.
    Frippiat F; Musuamba FT; Seidel L; Albert A; Denooz R; Charlier C; Van Bambeke F; Wallemacq P; Descy J; Lambermont B; Layios N; Damas P; Moutschen M
    J Antimicrob Chemother; 2015 Jan; 70(1):207-16. PubMed ID: 25216821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current guidelines for the treatment of severe pneumonia and sepsis.
    Bodmann KF
    Chemotherapy; 2005 Aug; 51(5):227-33. PubMed ID: 16103664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of gram-positive nosocomial pneumonia. Prospective randomized comparison of quinupristin/dalfopristin versus vancomycin. Nosocomial Pneumonia Group.
    Fagon J; Patrick H; Haas DW; Torres A; Gibert C; Cheadle WG; Falcone RE; Anholm JD; Paganin F; Fabian TC; Lilienthal F
    Am J Respir Crit Care Med; 2000 Mar; 161(3 Pt 1):753-62. PubMed ID: 10712318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Levofloxacin in the treatment of nosocomial infection in critically ill patients].
    Alvarez Lerma F; Romero Luján JL; Morón Jiménez A; Ortiz López R; Borges Sá M; Grau Cerrato S; Gracia Arnillas MP;
    Rev Esp Quimioter; 2008 Jun; 21(2):83-92. PubMed ID: 18509767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tigecycline Therapy for Nosocomial Pneumonia due to Carbapenem-Resistant Gram-Negative Bacteria in Critically Ill Patients Who Received Inappropriate Initial Antibiotic Treatment: A Retrospective Case Study.
    Wu X; Zhu Y; Chen Q; Gong L; Lin J; Lv D; Feng J
    Biomed Res Int; 2016; 2016():8395268. PubMed ID: 28044137
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhaled colistin as monotherapy for multidrug-resistant gram (-) nosocomial pneumonia: a case series.
    Falagas ME; Siempos II; Rafailidis PI; Korbila IP; Ioannidou E; Michalopoulos A
    Respir Med; 2009 May; 103(5):707-13. PubMed ID: 19118994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial incidence and antibiotic sensitivity pattern in moderate and severe infections in hospitalised patients.
    Ghosh A; Karmakar PS; Pal J; Chakraborty N; Debnath NB; Mukherjee JD
    J Indian Med Assoc; 2009 Jan; 107(1):21-2, 24-5. PubMed ID: 19588683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Meropenem-Vaborbactam vs Piperacillin-Tazobactam on Clinical Cure or Improvement and Microbial Eradication in Complicated Urinary Tract Infection: The TANGO I Randomized Clinical Trial.
    Kaye KS; Bhowmick T; Metallidis S; Bleasdale SC; Sagan OS; Stus V; Vazquez J; Zaitsev V; Bidair M; Chorvat E; Dragoescu PO; Fedosiuk E; Horcajada JP; Murta C; Sarychev Y; Stoev V; Morgan E; Fusaro K; Griffith D; Lomovskaya O; Alexander EL; Loutit J; Dudley MN; Giamarellos-Bourboulis EJ
    JAMA; 2018 Feb; 319(8):788-799. PubMed ID: 29486041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and microbiological efficacy of continuous versus intermittent application of meropenem in critically ill patients: a randomized open-label controlled trial.
    Chytra I; Stepan M; Benes J; Pelnar P; Zidkova A; Bergerova T; Pradl R; Kasal E
    Crit Care; 2012 Jun; 16(3):R113. PubMed ID: 22742765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of Meropenem in preterm newborns. Survey of the literature and case series].
    De Cunto A; Tana M; Vendettuoli V; Tirone C; Boccacci S; Vento G; Romagnoli C
    Minerva Pediatr; 2007 Dec; 59(6):755-60. PubMed ID: 17978784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meropenem monotherapy for the treatment of hospital-acquired pneumonia: results of a multicenter trial.
    Berman SJ; Fogarty CM; Fabian T; Melnick D; Lesky W;
    J Chemother; 2004 Aug; 16(4):362-71. PubMed ID: 15332712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia.
    Heyland DK; Dodek P; Muscedere J; Day A; Cook D;
    Crit Care Med; 2008 Mar; 36(3):737-44. PubMed ID: 18091545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiological surveillance and antimicrobial stewardship minimise the need for ultrabroad-spectrum combination therapy for treatment of nosocomial infections in a trauma intensive care unit: an audit of an evidence-based empiric antimicrobial policy.
    Ramsamy Y; Muckart DJ; Han KS
    S Afr Med J; 2013 Mar; 103(6):371-6. PubMed ID: 23725954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.
    Michalopoulos A; Kasiakou SK; Mastora Z; Rellos K; Kapaskelis AM; Falagas ME
    Crit Care; 2005 Feb; 9(1):R53-9. PubMed ID: 15693967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative activity of meropenem and other antibiotics against the pathogens of nosocomial infections].
    Sidorenko SV; Rezvan SP; Grudinina SA; Sterkhova GV; Aleksandrova IA
    Antibiot Khimioter; 1998; 43(1):4-14. PubMed ID: 9532326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinico-microbiological profile and outcomes of nosocomial sepsis in an Indian tertiary care hospital--a prospective cohort study.
    Saravu K; Prasad M; Eshwara VK; Mukhopadhyay C
    Pathog Glob Health; 2015 Jul; 109(5):228-35. PubMed ID: 26184918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.